# The Infected Blood Compensation Scheme Regulations 2025, Paragraph 6: End-stage kidney disease requiring renal replacement therapy


A person (“P”) is to be treated as having end-stage kidney disease requiring renal replacement therapy if they have required renal replacement therapy for at least 3 months as a result of—
(a) where P has HIV, any of the following conditions—
(i) HIV-associated nephropathy;
(ii) HIV-associated immune complex chronic kidney disease;
(iii) drug associated kidney disease in conjunction with treatment with foscarnet socium, cidofovir or tenofovir disoproxil;
(b) where P has a Hepatitis B infection of severity level 2, 3 or 4, any of the following conditions—
(i) membranous nephropathy;
(ii) membranoproliferative glomerulonephritis including in the presence of mixed cryoglobulinaemic vasculitis;
(iii) IgA nephropathy;
(iv) tenofovir-induced renal failure;
(c) where P has a Hepatitis C infection of severity level 2, 3 or 4, membranoproliferative glomerulonephritis mainly in the presence of mixed cryoglobulinaemic vasculitis.

---
Source: https://www.legislation.gov.uk/ukdsi/2025/9780348268843/schedule/2/paragraph/6 (the official version)
Page: https://openlegislation.uk/draft-infected-blood-compensation-scheme-regulations-2025/schedule-2/paragraph-6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.